NEW YORK, Dec. 13, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities Abeona Therapeutics Inc. ("Abeona" or the "Company") (NASDAQ: ABEO). Such investors can obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/abeo.
The investigation concerns whether Abeona and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On December 12, 2016, Mako Research reported on SeekingAlpha.com that "ABEO science is demonstrably unviable with numerous irrefutable flaws that will lead to failure." Mako Research also revealed that Steven H. Rouhandeh, Abeona's Executive Chairman and Principal Executive Officer, was a former managing director at D. Blech & Co. brokerage firm, which was the subject of a SEC investigation in the 1990s, and a securities class action that reached $15 million settlement for investors, based on allegations that D. Blech & Co artificially manipulated the price of various biotech stocks and maintained the market price of the biotech stocks to keep its company's interest in the stocks afloat. Following this news, Abeona stock dropped during intraday trading on December 12, 2016.
If you are aware of any facts relating to this investigation, or purchased Abeona shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/abeo. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-abeona-therapeutics-inc-abeo-300377193.html
SOURCE Bronstein, Gewirtz & Grossman, LLC